possibly even tumorigenesis. These RNAs are also the key players in the process of RNA interference. This work focuses on the secondary structure analyses of micro RNAs and their precursors
biological activity and inefficient targeted delivery in vivo have hindered RNA interference (RNAi)-based therapy from realising its full clinical potential. To overcome these hurdles, progresses have been made
even life-long presence of therapeutic agents. Recent development in gene silencing applying both RNA interference and microRNA approaches will certainly expand the application range. Moreover, alphaviruses provide…
between non-cancer genes and bona-fide cancer genes. The use of our pioneering RNA interference (RNAi) technology to exanimate this novel genetic concept represents a highly innovative approach that
cell membrane. Importantly, we found that knock-down of TRIP-1 by RNA interference resulted in a blockade to Ezrin-induced hepatocellular carcinoma cell adhesion and migration by wound healing
tumor antigens has demonstrated prophylactic protection against cancer. Novel approaches include the application of RNA interference and microRNA. The other side of the coin is the development of vaccines against
types of HTS methods available, including targeted screening, diversity and high-content screening, and RNA interference (RNAi). These screens have been used effectively with a number of BSL-2 pathogens
Current vaccination strategies and antiviral drugs provide limited protection; therefore new strategies are needed. RNA interference is an effective means and is now widely used to knock-down gene expression
RNA interference (RNAi) is an evolutionarily conserved mechanism in eukaryotic cells, It is a gene down-regulatory process occurring in both nucleus and cytoplasm at different stages of cell cycles
fundamental to many genetics studies, such as PCR, microarray hybridization, Southern and Northern blotting, RNA interference (RNAi), and genome (re)sequencing. However, being unique sequence in the genome alone
RNA interference plays a significant role in manipulating cellular and viral mechanisms to maintain latency during HIV-1 infection. HIV-1 produces several microRNAs including one from the TAR element
genetic tools, could be overcome by the development of in ovo RNAi (in ovo RNA interference), a method that allows for temporal and spatial control of gene silencing in vivo
RNA interference (RNAi) is an endogenous process that regulates expression of genes and corresponding proteins to maintain homeostasis in diverse organisms. Non-coding RNAs (ncRNAs) including both long and short
RNA interference (RNAi) is a powerful tool in the study of gene function. We added poly(A) tails to the 3' ends of siRNA antisense strands by in vitro transcription
RNA interference (RNAi) is an exciting new tool to effect acute in vivo knockdown of genes for pharmacological target validation. Testing the application of this technology to metabolic disease targets
molecular mechanism of RNA interference (RNAi) is under intense investigation. We previously demonstrated the existence of inactive siRNAs and also of mRNA cleavage in vivo in human cells. Here
being a nucleic acid molecule, and also from the baggage it inherits from the RNA interference (RNAi) pathway, which is critical to the function of siRNAs
significantly up-regulated in LJB cells after poly I:C stimulation and NNV infection. RNA interference experiment demonstrated that silencing of LjMDA5 significantly increased NNV replication in NNV infected
various biochemical and biomedical applications due to their biocompatibility and surface modification potential. RNA interference (RNAi) agents, such as siRNA and shRNA, are highly specific to inhibit the target genes
nanoparticles, magnetic nanoparticles, polymeric nano-particles, liposomes are widely used for gene knockdown in RNA interference. However the key challenge of complete delivery of siRNA, biodegradability of…
RNA interference (RNAi)-based approaches have greatly contributed to better understanding of gene expression and function in vitro. The capability to apply these strategies in vivo in order to validate
generate HLA silenced PLTs from CD34+ cells or induced pluripotent stem cells (iPSCs) using RNA interference technology. We demonstrated that HLA-silenced PLTs are functional in vitro and efficiently protected
breast cancer cells. The GL treatment caused apoptotic cell death was significantly enhanced by RNA Interference of β-Catenin and TCF-4. Conclusion: the present study indicates that β-Catenin
cell lines, each expressing a different RTK, as signaling nodes were systematically perturbed by RNA interference. Network models were inferred from the resulting data for each RTK, revealing a conserved
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.